United Kingdom· GB-APID-28024411000001103
Vokanamet 50mg/1000mg tablets
A metformin and canagliflozin product containing canagliflozin + metformin, registered in United Kingdom by A. Menarini Farmaceutica Internazionale SRL. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Metformin and canagliflozin is registered in 11 of 19 countries.
Countries holding a registration under ATC A10BD16 (metformin and canagliflozin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Metformin and canagliflozin · ATC A10BD16
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Canagliflozin + Metformin
- Manufacturer
- A. Menarini Farmaceutica Internazionale SRL
- Country
- United Kingdom (GB)
- ATC code
- A10BD16
- ATC class
- Metformin and canagliflozin
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5012674902547
- gtin05012674902547
- gtin5012674904336
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for metformin and canagliflozin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and canagliflozin · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin and canagliflozin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesINVOKAMETJanssen Pharmaceuticals, Inc.
- CzechiaVOKANAMETJanssen-Cilag International N.V., Beerse
- SwitzerlandVokanamet 150 mg / 1000 mg, FilmtablettenJanssen-Cilag AG
- IcelandVokanametJanssen-Cilag International NV*
- NetherlandsVokanamet 150 mg/1.000 mg filmomhulde tablettenJanssen-Cilag International NV
- SwedenVokanamet 150 mg/1000 mg Filmdragerad tablettJanssen-Cilag International NV
- PolandVokanametJanssen-Cilag International N.V.
- SpainVOKANAMET 150 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULAJanssen-Cilag International N.V
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vokanamet
- Liechtenstein · Vokanamet
- Norway · Vokanamet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd5f44a5-4b75-4d6c-abf2-a7dc7132d082 GET /v1/drugs/dd5f44a5-4b75-4d6c-abf2-a7dc7132d082?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "28024411000001103",
"desc": "Vokanamet 50mg/1000mg tablets (A. Menarini Farmaceutica Internazionale SRL)",
"form": "Oral tablet",
"vpid": "28049211000001101",
"source": "dmd",
"vtm_id": "775026006",
"strength": "50 mg",
"substance": "Canagliflozin + Metformin",
"ingredient": "Canagliflozin hemihydrate",
"supplier_code": "3533901000001105"
}See everything about metformin and canagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.